- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT03491436
Pregnancy Remote Monitoring of Women at Risk for Gestational Diabetes
Background: Remote monitoring (RM) is a new screenings- and or diagnostic tool in healthcare. In 2015, the PREMOM study (Pregnancy Remote Monitoring), in which patients with gestational hypertensive diseases did received a RM prenatal follow up, has started. The first results showed an added value of RM in the prenatal follow-up. Due to these results, a RM program for pregnant women with gestational diabetes mellitus (GDM) will be developed and evaluated.
Protocol: Women (at risk of) GDM will be included in this study. They receive a iHealth Align (a glucose monitor) and associated glycemiestrips. The app of iHealth will be downloaded on the pregnant women's Smartphone to collect the data and to send them to the researcher in the hospital.
The women is asked to perform four glycemie controls/day (sober and two hours after every mail) with the received glucose monitor. The monitor is connected via Wi-Fi and Bluetooth with the computer of the researches who controls and evaluated these data. Additionally, the pregnant women has to check daily her body weight with a weight scale of her own. They have to upload these data manually in the app on her smartphone.
When the pregnant women has an prenatal consultation, an overview with the data will be send to the responsible gynecologist. The gynecologist will also be alarmed when the pregnant women has three abnormal values at the same moment of the day (ex. Every morning after breakfast). When necessary, advice among life-style can be given or a referral to an endocrinologist can be made. The researches will not perform interventions by herself, only the responsible doctor can do this.
By analyzing the patients parameters when she's at home, a better vision can be achieved of the health of the mother and the child. This study will be conducted as a first research to get a better insight in the added value of RM in pregnancies complicated with GDM.
Přehled studie
Typ studie
Fáze
- Nelze použít
Kontakty a umístění
Studijní místa
-
-
-
Genk, Belgie, 3600
- Ziekenhuis Oost-Limburg
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
- women with confirmed GDM or at risk for this disease. Pregnancies > 10 weeks of gestation, primipara and multipara.
Exclusion Criteria:
- pregnancies < 10 weeks of gestation, congenital malformations of the fetus
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Prevence
- Přidělení: N/A
- Intervenční model: Přiřazení jedné skupiny
- Maskování: Žádné (otevřený štítek)
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
---|---|
Experimentální: Remote monitoring group
Women (at risk of) GDM will be included in this study.
They receive a iHealth Align (a glucose monitor) and associated glycemiestrips.
The app of iHealth will be downloaded on the pregnant women's Smartphone to collect the data and to send them to the researcher in the hospital.
|
remote monitor glucometer
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
---|---|---|
Blood glucose sober
Časové okno: an average of 30 weeks
|
The women is asked to perform four glycemie controls/day (sober and two hours after every mail) with the received glucose monitor. The monitor is connected via Wi-Fi and Bluetooth with the computer of the researches who controls and evaluated these data. Has both mother and child advantages when the mother is screened and provided with the remote monitoring devices? is RM acceptable to use in the prenatal care for GDM and does it have in added value in gestational outcomes? |
an average of 30 weeks
|
Weight once a day
Časové okno: an average of 30 weeks
|
the pregnant women has to check daily her body weight with a weight scale of her own. They have to upload these data manually in the app on her smartphone. Has both mother and child advantages when the mother is screened and provided with the remote monitoring devices? is RM acceptable to use in the prenatal care for GDM and does it have in added value in gestational outcomes? |
an average of 30 weeks
|
blood glucose 2 hours after meal 1
Časové okno: an average of 30 weeks
|
The women is asked to perform four glycemie controls/day (sober and two hours after every mail) with the received glucose monitor. The monitor is connected via Wi-Fi and Bluetooth with the computer of the researches who controls and evaluated these data. Has both mother and child advantages when the mother is screened and provided with the remote monitoring devices? is RM acceptable to use in the prenatal care for GDM and does it have in added value in gestational outcomes? |
an average of 30 weeks
|
blood glucose 2 hours after meal 2
Časové okno: through study completion
|
The women is asked to perform four glycemie controls/day (sober and two hours after every mail) with the received glucose monitor. The monitor is connected via Wi-Fi and Bluetooth with the computer of the researches who controls and evaluated these data. Has both mother and child advantages when the mother is screened and provided with the remote monitoring devices? is RM acceptable to use in the prenatal care for GDM and does it have in added value in gestational outcomes? |
through study completion
|
blood glucose 2 hours after meal 3
Časové okno: an average of 30 weeks
|
The women is asked to perform four glycemie controls/day (sober and two hours after every mail) with the received glucose monitor. The monitor is connected via Wi-Fi and Bluetooth with the computer of the researches who controls and evaluated these data. Has both mother and child advantages when the mother is screened and provided with the remote monitoring devices? is RM acceptable to use in the prenatal care for GDM and does it have in added value in gestational outcomes? |
an average of 30 weeks
|
Spolupracovníci a vyšetřovatelé
Sponzor
Vyšetřovatelé
- Vrchní vyšetřovatel: Wilfried Gyselaers, prof. dr., Hasselt University
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Aktuální)
Dokončení studie (Aktuální)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Další relevantní podmínky MeSH
Další identifikační čísla studie
- PRM-001
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na Těhotenství Diabetika
-
University Hospital, MontpellierDokončeno
-
Bnai Zion Medical CenterNeznámý
-
Hadassah Medical OrganizationDokončeno
-
Pennington Biomedical Research CenterDokončenoDiabetik typu 2Spojené státy
-
Assistance Publique - Hôpitaux de ParisNational Research Agency, FranceNáborDiabetik | Kardiovaskulární komplikace | GlutaminFrancie
-
Hospital General de MexicoNeznámýHojení ran | DiabetikMexiko
-
University of PlymouthUniversity Hospital Plymouth NHS TrustNeznámýDiabetik | Neuropatické | Minulá ulceraceSpojené království
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR)DokončenoDiabetik | KardiovaskulárníKanada
-
Hospices Civils de LyonZatím nenabírámeKoronární stenóza | DiabetikFrancie
Klinické studie na iHealth Align
-
University of Colorado, DenverKaiser PermanenteDokončenoPokročilé lékařské onemocněníSpojené státy
-
University of California, San FranciscoLivongo HealthDokončenoDiabetes MellitusSpojené státy
-
Leslie Balcazar De MartinezDokončenoGestační diabetes mellitusSpojené státy
-
Hospital Universitari Vall d'Hebron Research InstituteInstitut d'Investigació Biomèdica de Girona Dr. Josep Trueta; Hospital Universitari... a další spolupracovníciDokončenoStresová močová inkontinence u ženŠpanělsko
-
William Beaumont HospitalsUkončenoFibróza, játra | Cirhóza, játra | Steatohepatitida, nealkohol | Ztukovatění jaterSpojené státy
-
Hasselt UniversityZiekenhuis Oost-LimburgNáborGestační diabetes | TelemonitoringBelgie
-
Rutgers, The State University of New JerseyDokončenoHypertenzeSpojené státy
-
University of Turin, ItalyDokončeno
-
AIDS Healthcare FoundationHIV Immunotherapeutics InstituteDokončenoHIV-1-infekce | Střevní zánětSpojené státy